Case Study
Rebrand signals a message of hope
Industry
Biotechnology and Pharmaceuticals
What we did
Brand Platform
Branding
Discovery
Logo Design
Naming
Reporting
Visual Identity
Website
Insight
How do you redefine a clinical research organisation without relying on the word “science”? Neurizon (formerly PharmAust Limited) was constrained by a misaligned proposition and an identity that misrepresented and obscured its potential.
We repositioned the brand from an animal research and products business to a cutting-edge powerhouse in neurodegenerative research. This was a bold strategic pivot – moving beyond a simple refresh to articulate a dedication to life-changing discoveries. By leveraging technical expertise and a new, clear pathway, Neurizon is now positioned for global leadership in neurodegenerative disease treatments.
Creative Vision
The new identity needed to feel as advanced as the research it represents. We conceived a modern, scalable branding system, grounded in clarity, focus and hope – distilling complex neurodegenerative research and human emotion into a calm and assuring aesthetic. A distinctive colour palette and dynamic graphic language project authority and sophistication across all platforms. Our vision was to provide Neurizon with a forward-looking face: a global leader dedicated to illuminating the future of neurodegenerative treatments and pioneering novel breakthroughs.
Impact
The strategic rebrand transformed Neurizon’s internal and external perceptions, repositioning it as a pioneer in neurodegenerative treatment research. The strategic platform and new visual identity unified researchers, investors, patients and clinical partners, fostering deeper and more engaged relationships. By delivering a cohesive visual and verbal platform, we empowered Neurizon to attract new investment and secure critical partnerships. Neurizon now owns its future as an industry leader, guided by a clear vision pathway.
Collaborating with Collier on Neurizon Therapeutics’ brand development has been an exceptional journey.
Lidija Damjanovic, Head of Marketing and Corporate Affairs
Collaborating with Collier on Neurizon Therapeutics’ brand development has been an exceptional journey. From the outset, their team approached the project with a keen understanding of our strategy and mission.
Lidija Damjanovic, Head of Marketing and Corporate Affairs
One of Collier’s standout strengths was their in-depth competitor analysis, which allowed them to strategically position Neurizon with a unique voice and compelling visual presence in a competitive market.
Lidija Damjanovic, Head of Marketing and Corporate Affairs
